The medical device market has been in the spotlight ever since coronavirus tightened its grip across the world last year as the
IPO Alert: What investors need to know about Procept BioRobotics’ upcoming market debut
Categories
Biotechnology
IPO News: Should you invest in RenovoRx’s upcoming IPO?
As healthcare startups continue to flock to the stock market, extending the hectic activity seen in the first half, the IPO market
Cara Therapeutics, Inc. CARA) Q2 2021 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ: CARA) Q2 2021 earnings call dated Aug. 09, 2021 Corporate Participants: Cole Herlitz-Ferguson -- Investor Relations Derek Chalmers -- Chief Executive Officer,
IPO News: What to look for when Eliem Therapeutics goes public?
Extending the IPO frenzy that sweeped the market in the early part of the year, emerging biotechnology companies continue to flock to
Moderna, Inc. (MRNA) Q2 2021 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q2 2021 earnings call dated Aug. 05, 2021 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head of Investor
Jazz Pharmaceuticals PLC (JAZZ) Q2 2021 Earnings Call Transcript
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) Q2 2021 earnings call dated Aug. 03, 2021 Corporate Participants: Andrea N. Flynn -- Vice President and Head of
IPO News: What awaits Adagio Therapeutics after stock market debut?
The favorable regulatory environment and convenient options like direct listing continue to lure emerging businesses to the stock market. The latest statistics
IPO News: Here’s everything you need to know about Healthcare Royalty’s upcoming IPO
In the first half of 2021, a record number of private companies entered stock markets in the US, marking a multifold increase
ImmunoGen Inc. (IMGN) Q2 2021 Earnings Call Transcript
ImmunoGen Inc. (NASDAQ: IMGN) Q2 2021 earnings call dated Jul. 30, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
Gilead Sciences Inc (GILD) Q2 2021 Earnings Call Transcript
Gilead Sciences Inc (NASDAQ: GILD) Q2 2021 earnings call dated Jul. 29, 2021. Corporate Participants: Jacquie Ross -- Investor Relations Daniel O'Day --
WCG Clinical IPO: Here’s what you should know before investing in the stock
Of late healthcare firms have been flocking to Wall Street, betting on the booming stock market to take their business expansion to
Biogen (BIIB) Earnings Infographic: Q2 profit, revenue drop but top estimates
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however, came in
Absci IPO: Here’s all you need to know about bioengineering firm’s Nasdaq listing
Wall Street is probably going through the busiest phase since the recession, in terms of the number of businesses seeking to go
IPO News: Here’s what to know when Sera Prognostics goes public this week
The healthcare industry continues to grow at a rapid pace with diagnostic services playing an important role in this space. Women’s health
Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2021 earnings call dated Jun. 29, 2021 Corporate Participants: Tim Brons -- Executive Vice President, Vida Strategic Partners,
Thermo Fisher (TMO) stock can add value to your portfolio. Here’s why
For Thermo Fisher Scientific Inc. (NYSE: TMO), a leading player in the medical diagnostics and life sciences market, 2020 was a busy
Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development
IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a
IPO News: What to look for when Elevation Oncology makes its Wall Street debut
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly
BeyondSpring, Inc.(BYSI) Q1 2021 Earnings Call Transcript
BeyondSpring, Inc. (NASDAQ: BYSI) Q1 2021 earnings call dated Jun. 16, 2021 Corporate Participants: Ashley R. Robinson -- Media & Investor Relations of LifeSci
Is Merck (MRK) stock still a buy after losing the vaccine race?
After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the mass production